[HTML][HTML] Treatment with hydroxychloroquine vs nitazoxanide in patients with COVID-19: brief report
JM Calderón, S Padmanabhan… - PAMJ-Clinical …, 2021 - clinical-medicine.panafrican-med …
Introduction: coronavirus pandemic has led to 1.8 million deaths worldwide as of May 1 st,
2021. Nitazoxanide (NTZ) is currently being studied in several ambulatory clinical trials to …
2021. Nitazoxanide (NTZ) is currently being studied in several ambulatory clinical trials to …
[HTML][HTML] COVID-2019: Una revisión de la nueva crisis pandémica
RR Contreras - Revista Digital Novasinergia, 2020 - scielo.senescyt.gob.ec
La pandemia del COVID-19, causada por el nuevo coronavirus 2019-nCoV y responsable
del síndrome respiratorio agudo severo por coronavirus 2 (SARS-CoV-2), constituye un …
del síndrome respiratorio agudo severo por coronavirus 2 (SARS-CoV-2), constituye un …
[HTML][HTML] From universal frames to collective experimentation? Pursuing serious conversations about antimicrobial resistance
C Will, A Kamenshchikova - Wellcome Open Research, 2020 - wellcomeopenresearch.org
In the time of coronavirus disease 2019 (COVID-19) there are numerous attempts to
compare across national boundaries and rank governments for their action against the virus …
compare across national boundaries and rank governments for their action against the virus …
Патоморфологическая и иммуногистохимическая характеристика изменений лимфатических узлов у умерших от COVID-19 по данным аутопсий
АМ Ковригина, ЕА Шаламова… - Научно-практический …, 2020 - cem-journal.ru
Аннотация Введение. Патогенез новой коронавирусной инфекции COVID-19
находится в стадии активного изучения. Тем не менее сведения об изменениях …
находится в стадии активного изучения. Тем не менее сведения об изменениях …
O AUMENTO DAS RESISTÊNCIAS BACTERIANAS ASSOCIADO AO USO DE ANTIMICROBIANOS DURANTE A PANDEMIA DE COVID-19: UMA REVISÃO …
A de Santana Souza, FP da Silva… - Revista …, 2023 - ojs.revistacontemporanea.com
O uso de antimicrobianos representa um impacto social significativo na história da
humanidade, uma vez que possibilitou o aumento na estimativa de vida das pessoas ao …
humanidade, uma vez que possibilitou o aumento na estimativa de vida das pessoas ao …
Immunosuppression is a Double-Edged Sword in COVID-19 Treatment: a Case Report of Rhino-Orbito-Cerebral Mucormycosis.
M Sedaghattalab, T Bagheri… - Clinical …, 2022 - search.ebscohost.com
Background: Mucormycosis is a life-threatening fungal infection mostly occurring in
immunosuppressed patients such as organ transplant or diabetic patients. In this paper, we …
immunosuppressed patients such as organ transplant or diabetic patients. In this paper, we …
Síndrome de liberación de citocinas en infección por COVID-19 y administración de tocilizumab como opción terapéutica
M Prado-Rodríguez, Y Robles-Abarca… - Medicina Interna de …, 2022 - medigraphic.com
La pandemia derivada por el nuevo síndrome respiratorio agudo severo coronavirus 2
(SARS-CoV-2), agente causal de la enfermedad por coronavirus 2019 (COVID-19), ha …
(SARS-CoV-2), agente causal de la enfermedad por coronavirus 2019 (COVID-19), ha …
[PDF][PDF] A evolução do tratamento de doentes COVID-19 durante as várias fases da Pandemia num Hospital Central Português-Uma retrospetiva
TAA Vieira - 2022 - repositorio-aberto.up.pt
Introdução: A Coronavirus disease 2019 veio trazer uma grande quantidade de doentes
com uma nova doença pouco compreendida, sendo necessário estratificar e tratar estes …
com uma nova doença pouco compreendida, sendo necessário estratificar e tratar estes …
In Silico Analysis of the Inhibitory Potential of Zingiber Officinale Roscoe Compounds Against SARS-CoV-2
T Ernawati - 1st International Conference for Health Research …, 2023 - atlantis-press.com
In traditional medicine, Z. officinale has been known and used for centuries. However, with
the current ongoing COVID-19 pandemic, Z. officinale is increasingly being used to treat …
the current ongoing COVID-19 pandemic, Z. officinale is increasingly being used to treat …
Az új típusú koronavírus okozta megbetegedés (COVID–19): összefoglaló hematológusoknak II.–a diagnosztika, terápia és prevenció lehetőségei
Absztrakt: A COVID–19 a SARS-CoV-2 vírus által okozott, járványosan terjedő, légúti
kiindulású betegség. A kórokozó magas patogenitású, zoonotikus eredetű humán …
kiindulású betegség. A kórokozó magas patogenitású, zoonotikus eredetű humán …